D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery

Surgery Today

Volumn 39, Issue 3, 2009, Pages 207-213

  Hu, Jian Kun ^a   Yang, Kun ^a   Zhang, Bo ^a   Chen, Xin Zu ^a   Chen, Zhi Xin ^a   Chen, Jia Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gastric cancer; Lymphadenectomy; Morbidity; Mortality; Para aortic lymph nodes; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARAAORTIC LYMPH NODE; RANDOMIZED CONTROLLED TRIAL; SPLENECTOMY; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GASTRECTOMY; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SAFETY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 62449129144     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-008-3856-x     Document Type: Article

References (25)

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology™ gastric cancer V.2.2007. URL: http://www.nccn.org/ professionals/physician-gls/PDF/gastric.pdf. Accessed 2 Mar 2008.
2. S. Takashima T. Kosaka 2005 Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer Surg Today 35 425 431
3. C. Kunisaki H. Shimada H. Yamaoka J. Wakasugi M. Takahashi H. Akiyama 1999 Significance of para-aortic lymph node dissection in advanced gastric cancer Hepatogastroenterology 46 2635 2642
4. D. Marrelli C. Pedrazzani A. Neri G. Corso A. DeStefano E. Pinto 2007 Complications after extended (D2) and super-extended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors Ann Surg Oncol 14 25 33
5. M. Nakamura Y. Kido Y. Hosoya M. Yano H. Nagai M. Monden 2007 Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer Surg Today 37 379 382
6. Japanese Gastric Cancer Association. 1998 Japanese classification of gastric carcinoma Gastric Cancer 1 10 24
7. H.H. Hartgrink C.J. van de Velde H. Putter J.J. Bonenkamp E. Klein Kranenbarg I. Songun 2004 Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2069 2077
8. A. Cuschieri P. Fayers J. Fielding J. Craven J. Bancewicz V. Joypaul 1996 Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 347 995 999
9. J.J. Bonenkamp I. Songun J. Hermans M. Sasako K. Welvaart J.T. Plukker 1995 Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 745 748
10. T. Sano M. Sasako S. Yamamoto A. Nashimoto A. Kurita M. Hiratsuka 2004 Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501 J Clin Oncol 22 2767 2773
11. C.W. Wu C.A. Hsiung S.S. Lo M.C. Hsieh J.H. Chen A.F. Li 2006 Nodal dissection for patients with gastric cancer: a randomised controlled trial Lancet Oncol 7 309 315
12. C. Kunisaki H. Shimada M. Takahashi M. Nomura G. Matsuda Y. Otsuka 2003 Implication of extended lymph node dissection stratified for advanced gastric cancer Anticancer Res 23 4181 4186
13. K. Günther T. Horbach S. Merkel M. Meyer U. Schnell P. Klein 2000 D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications Surg Today 30 700 705
14. S. Shimoyama K. Mafune M. Kaminishi 2005 Safety of a paraaortic node dissection for selected advanced gastric cancer patients Hepatogastroenterology 52 1631 1635
15. Y. Yonemura C.C. Wu N. Fukushima I. Honda E. Bandou T. Kawamura 2006 East Asia Surgical Oncology Group. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons Hepatogastroenterology 53 389 394
16. C. Kunisaki H. Akiyama M. Nomura G. Matsuda Y. Otsuka H. Ono 2006 Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study Ann Surg Oncol 13 659 667
17. E. Nomura M. Sasako S. Yamamoto T. Sano T. Tsujinaka T. Kinoshita 2007 Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group. Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501 Jpn J Clin Oncol 37 429 433
18. Y. Yonemura C.C. Wu N. Fukushima I. Honda E. Bandou T. Kawamura 2007 East Asia Surgical Oncology Group. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy Hepatogastroenterology 54 634 638
19. T. Kosaka K. Usami N. Ueshige T. Hasegawa S. Yoshitani J. Sugaya 2006 Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases Hepatogastroenterology 53 629 633
20. M. Nomura C. Kunisaki H. Akiyama G. Matsuda Y. Otsuka H. Ono 2005 Surgical outcome of para-aortic lymph node dissection preserving neural tissue based on anatomical evaluations J Gastrointest Surg 9 781 788
21. M. Maeta H. Saito A. Kondo H. Yamashiro S. Tsujitani M. Ikeguchi 1998 Effects of super-extended paraaortic lymphadenectomy (PAL) on biological responses in totally gastrectomized patients with T3 or T4 gastric cancer Gastric Cancer 1 57 63
22. J. Kulig T. Popiela P. Kolodziejczyk M. Sierzega A. Szczepanik 2007 Polish Gastric Cancer Study Group. Standard D2 versus extended D2 (D2 +) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial Am J Surg 193 10 15
23. M. Sasako T. Sano S. Yamamoto Y. Kurokawa A. Nashimoto A. Kurita 2008 D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 453 462
24. K.K. Roggin M.C. Posner 2006 D3 or not D3 that is not the question Lancet Oncol 7 279 280
25. F. Tanaka 2007 UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction Surg Today 37 923 943